The Optics, Photonics and Biohotonics Group (GOFB) is specialized in Research, Technological Development and Innovation of advanced chemical, biochemical and in-vitro diagnostic systems, as well as in the implementation of photonic transducers and bio transducers on a chip, biokits, readout platforms, bioreactors, tissue-on-a-chip and organ-on-chips.
Dr. Miguel Holgado Bolaños graduated in Industrial Engineering from the Polytechnic University of Madrid (UPM) in 1996. D. in Industrial Engineering from the UPM in 2000. I did my doctoral thesis at the Instituto de Ciencia de los Materiales de Madrid (ICMM), belonging to the Consejo Superior de Investigaciones Científicas (CSIC).
Principal Investigator of the Organs and Tissues on Chips and In-vitro Detection Systems Group at the Health Research Institute of the Hospital Clínico San Carlos (IDISSC), Principal Investigator of the Optics, Photonics and Biophotonics Group at the Biomedical Technology Centre (CTB) of the UPM, Senior Lecturer in Applied Physics and Materials Engineering at the School of Industrial Engineering of the UPM. Accredited to University Professor in September 2021.
“I worked as R&D Engineer in the Laser Studies Section of the Ministry of Defence, I was responsible for the RAMAN spectroscopy service at the ICMM-CSIC. I worked for 4 years as a process engineer at Lucent Technologies Microelectronics, I was the Spanish representative in the 5th and 6th R&D Framework Programme at the Industrial Technology Centre (CDTI), deputy director of R&D projects at the Nanophotonics Technology Centre of the Polytechnic University of Valencia, head of Service of the European Communities Unit of the CSIC and Deputy Vice-Rector for Innovation at the UPM for 4 years. In 2007 I set up my research group at the UPM, where I currently work”.
I have directed or participated in more than 37 research projects: 11 European projects (4 as principal investigator), 26 national and regional projects (9 as principal investigator), 8 contracts with the industrial sector, as well as other industrial and R&D initiatives.
I am author/co-author of more than 150 scientific contributions, of which 61 are JCR articles of which more than 90% are Q1.
My papers have been cited more than 2700 times. I have directed/co-directed 7 doctoral theses and I am also inventor of 8 patents, of which 5 were licensed to the industrial sector.
The main objective is the development of Tissue on-a-chip platforms with integrated In-Vitro diagnostic systems for Therapy evaluation and personalized medicine. Moreover, the continuous development of advanced In-Vitro diagnostic systems for multiple applications.
